Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04114994 · ClinicalTrials.gov registry record
Longitudinal Cognitive Assessment by BoCA
A clinical trial of Multiple Sclerosis and Alzheimer Disease, sponsored by Alzheimer's Light.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT04114994: Recruiting study of Multiple Sclerosis and Alzheimer Disease, sponsored by Alzheimer's Light.
NCT04114994 is a study of Multiple Sclerosis and Alzheimer Disease that is actively recruiting participants, run by Alzheimer's Light. The registered enrollment target is 10,000 participants, above the 553-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (1708% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04114994, a study of Multiple Sclerosis and Alzheimer Disease, is actively recruiting participants, sponsored by Alzheimer's Light.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.
Primary Outcome
The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Boston Cognitive Assessment (BoCA)
Study Locations (1)
Florida
- Andrey Vyshedskiy - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2029-10-01 |
What NCT04114994 shows while recruiting
NCT04114994 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 553-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (1708% higher).
The record links to 7 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Boston Cognitive Assessment (BoCA) is the first listed.
NCT04114994 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04114994 about?
NCT04114994 is a clinical study titled "Longitudinal Cognitive Assessment by BoCA". The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to...
What is the current status of trial NCT04114994?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2019-10-01. Estimated completion is 2029-10-01.
What conditions does trial NCT04114994 study?
This clinical trial studies the following conditions: Multiple Sclerosis, Alzheimer Disease, Parkinson Disease, Mild Cognitive Impairment, Frontotemporal Dementia.
What interventions are being tested in trial NCT04114994?
The interventions under investigation include: Boston Cognitive Assessment (BoCA) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04114994?
This trial is sponsored by Alzheimer's Light, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04114994 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04114994's enrollment target sits among peer trials
10,000 4th of 315 higher than 312 of 315 other Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI